MSNBC The Rachel Maddow Show October 15, 2021 04:17:00
Presented, we know that j&j's own two dose study studies, so j&j with j&j. shows that a second dose of j&j increases protection by about 20%, against moderate to severe disease. so that is very good news. but you're also talking, the committee will also look at, what's known as the mix and match studies. these results are very exciting. the company didn't do these, but the nih did these. and the mix and match studies give excellent boosts, certainly with her guards to at antibodies, so let's see what the fda recommends. >> fascinating. talking about what the companies have done, and what the c...